Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort Study.

Autor: Vasylyev, Marta1 (AUTHOR), Wit, Ferdinand W N M2 (AUTHOR), Jordans, Carlijn C E1 (AUTHOR), Soetekouw, Robin3 (AUTHOR), Lelyveld, Steven F L van3 (AUTHOR), Kootstra, Gert-Jan4 (AUTHOR), Delsing, Corine E4 (AUTHOR), Ammerlaan, Heidi S M5 (AUTHOR), Kasteren, Marjo E E van6 (AUTHOR), Brouwer, Annemarie E6 (AUTHOR), Leyten, Eliane M S7 (AUTHOR), Claassen, Mark A A8 (AUTHOR), Hassing, Robert-Jan8 (AUTHOR), Hollander, Jan G den9 (AUTHOR), van den Berge, Marcel10 (AUTHOR), Roukens, Anna H E11 (AUTHOR), Bierman, Wouter F W12 (AUTHOR), Groeneveld, Paul H P13 (AUTHOR), Lowe, Selwyn H14 (AUTHOR), Welzen, Berend J van15 (AUTHOR)
Zdroj: Open Forum Infectious Diseases. Apr2024, Vol. 11 Issue 4, p1-10. 10p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje